Remeron and Rifaximin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Remeron (mirtazapine) and Rifaximin (rifaximin). Common drug interactions include myelofibrosis among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Remeron and Rifaximin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,474 Remeron users. Check the latest studies of Remeron.

What is Rifaximin?

Rifaximin has active ingredients of rifaximin. eHealthMe is studying from 3,597 Rifaximin users. Check the latest studies of Rifaximin.



On Jul, 11, 2026

11 people who take Remeron and Rifaximin together, and have interactions are studied.

Remeron and Rifaximin drug interactions.

What are the common drug interactions of Remeron and Rifaximin, by gender? *:

female:

  1. Myelofibrosis (a disease in which abnormal blood cells and fibres build up inside the bone marrow)
  2. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  3. Asthenia (weakness)
  4. Cardiac arrest
  5. Confusional state
  6. Cough
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Vomiting

male:

  1. Anaemia (lack of blood)
  2. Anti-erythropoietin antibody positive
  3. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  4. Hypoxia (low oxygen in tissues)
  5. Lung disorder (lung disease)
  6. Pneumonia
  7. Renal injury (kidney injury)
  8. Chronic kidney disease
  9. Renal failure (kidney dysfunction)
  10. Asthenia (weakness)

What are the common drug interactions of Remeron and Rifaximin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)

50-59:

n/a

60+:

  1. Myelofibrosis (a disease in which abnormal blood cells and fibres build up inside the bone marrow)
  2. Anaemia (lack of blood)
  3. Chronic kidney disease
  4. Cough
  5. Death
  6. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  7. Hypoxia (low oxygen in tissues)
  8. Lung disorder (lung disease)
  9. Pneumonia
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 27.27%
  2. Pain: 2 people, 18.18%
  3. Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 18.18%
  4. Hepatocellular Carcinoma (liver cancer): 2 people, 18.18%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
  6. Nausea And Vomiting: 1 person, 9.09%
  7. Nausea (feeling of having an urge to vomit): 1 person, 9.09%
  8. Metastases To Lung (cancer spreads to lung): 1 person, 9.09%
  9. Metastases To Liver (cancer spreads to liver): 1 person, 9.09%
  10. Hyperkalemia (damage to or disease of the kidney): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Remeron and Rifaximin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Remeron and Rifaximin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rifaximin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remeron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rifaximin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine and rifaximin (the active ingredients of Remeron and Rifaximin, respectively), and Remeron and Rifaximin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: